Blog | Oncotarget

Tomivosertib Versus Acute Myeloid Leukemia

In the cover paper chosen for Oncotarget’s Volume 12, Issue 10, researchers investigated the... read more

By Kathryn Atkins May 12, 2021

Read short summaries of the latest oncology-focused research published in this week’s issue of... read more

By Oncotarget May 11, 2021

Dr. Gregory Riggins from Johns Hopkins University discusses his 2017 study published by Oncotarget, entitled, "... read more

By Oncotarget May 10, 2021

In this trending study, the association between IGF/CTP composite scores, overall survival, and progression-free... read more

By Kathryn Atkins May 7, 2021

Dr. Kenneth J. Pienta and Dr. J. James Frost describe their 2017 study published by... read more

By Oncotarget May 3, 2021

Researchers from Yale University conducted a study to create mibefradil analogs as superior radiosensitizers in... read more

By Kathryn Atkins April 28, 2021

Read short summaries of the latest research published by Oncotarget.Origin: Connecticut, ... read more

By Oncotarget April 27, 2021

Researchers from NYU discuss their 2018 study published in Oncotarget, entitled, "Prognostic role of elevated... read more

By Oncotarget April 26, 2021

Researchers examined midostaurin resistance and sensitivity in a cohort of patients with acute myeloid leukemia.... read more

By Kathryn Atkins April 22, 2021

Harvard Medical School Professor Frank Slack discusses his 2016 study published in Oncotarget, entitled, “Cis-acting... read more

By Oncotarget April 18, 2021